Firazyr

Icatibant Acetate

Icatibant, sold under the brand name Firazyr, is a medication for the symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults with C1-esterase-inhibitor deficiency.[4][2][3] It is not effective in angioedema caused by medication from the ACE inhibitor class.[5] It is a peptidomimetic consisting of ten amino acids, which is a selective and specific antagonist of bradykinin B2 receptors. Contents 1 Mechani...

Drug Index

Icatibant, sold under the brand name Firazyr, is a medication for the symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults with C1-esterase-inhibitor deficiency.[4][2][3] It is not effective in angioedema caused by medication from the ACE inhibitor class.[5] It is a peptidomimetic consisting of ten amino acids, which is a selective and specific antagonist of bradykinin B2 receptors. Contents 1 Mechani...

NDC Database

Firazyr 30 mg/3ml Subcutaneous Injection, Solution by Shire Us Manufacturing Inc. ## Package Codes: 54092-135-01, 54092-135-02 ## Active Ingredients: Icatibant Acetate

NDC Database

Firazyr 30 mg/3ml Subcutaneous Injection, Solution by Shire Us Manufacturing Inc. ## Package Codes: 54092-702-01, 54092-702-02, 54092-702-03 ## Active Ingredients: Icatibant Acetate